Deutsch English Français

Contact

EP1537878

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1537878

EP1537878 - IMMUNOPOTENTIATING COMPOSITIONS [Right-click to bookmark this link]
Status	Opposition rejected Status updated on 15.12.2017 Database last updated on 26.06.2024
Most recent event Tooltip	15.12.2017	Opposition rejected	published on 17.01.2018 [2018/03]
Applicant(s)	For all designated states ONO PHARMACEUTICAL CO., LTD. 1-5, Doshomachi 2-chome Chuo-ku Osaka-shi, Osaka 541-8526 / JP
	For all designated states Honjo, Tasuku 19-4, Ohsagi-cho Iwakura Sakyo-ku Kyoto-shi Kyoto 606-0001 / JP
	[N/P]
Former [2010/38]	For all designated states ONO PHARMACEUTICAL CO., LTD. 1-5, Doshomachi 2-chome Chuo-ku Osaka-shi, Osaka 541-8526 / JP
	For all designated states Honjo, Tasuku 19-4, Osagi-cho, Iwakura, Sakyo-ku Kyoto-shi Kyoto 606-0001 / JP
Former [2005/23]	For all designated states ONO PHARMACEUTICAL CO., LTD. 1-5, Doshomachi 2-chome, Chuo-ku Osaka-shi, Osaka 541-8526 / JP
	For all designated states Honjo, Tasuku 19-4, Osagi-cho, Iwakura, Sakyo-ku Kyoto-shi, Kyoto 606-0001 / JP
Inventor(s)	01 / HONJO, Tasuku 19-4, Osagi-cho, Iwakura, Sakyo-ku Kyoto-shi, Kyoto 606-0001 / JP
	02 / MINATO, Nagahiro 10-36, Kamitakeya-cho, Takano, Sakyo-ku Kyoto-shi, Kyoto 606-8105 / JP
	03 / IWAI, Yoshiko, c/o The Rockefeller University Lab. Cellular Phys. and Immunol. 1230 York Avenue New York, NY 10021 / US
	04 / SHIBAYAMA, Shiro, c/o Ono Pharmaceutical Co., Ltd. 17-2, Wadai Tsukuba-shi, Ibaraki 300-4247 / JP
	[2006/23]
Former [2005/23]	01 / HONJO, Tasuku 19-4, Osagi-cho, Iwakura, Sakyo-ku Kyoto-shi, Kyoto 606-0001 / JP
	02 / MINATO, Nagahiro 10-36, Kamitakeya-cho, Takano, Sakyo-ku Kyoto-shi, Kyoto 606-8105 / JP
	03 / IWAI, Yoshiko 201-403, Kamiikesu-cho, Kamigyo-ku Kyoto-shi, Kyoto 602-0855 / JP
	04 / SHIBAYAMA, Shiro, c/o Ono Pharmaceutical Co., Ltd. 17-2, Wadai Tsukuba-shi, Ibaraki 300-4247 / JP
Representative(s)	Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstraße 4 80802 München / DE
	[N/P]
Former [2011/24]	Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät Leopoldstrasse 4 80802 München / DE
Former [2009/41]	Schön, Christoph, et al Kroher.Strobel Rechts- und Patentanwälte Bavariaring 20 80336 München / DE
Former [2005/23]	Henkel, Feiler & Hänzel Möhlstrasse 37 81675 München / DE
Application number, filing date	03741154.3	02.07.2003
	[2005/23]
	WO2003JP08420
Priority number, date	JP20020194491	03.07.2002 Original published format: JP 2002194491
	JP20030029846	06.02.2003 Original published format: JP 2003029846
	[2005/23]
Filing language	JA
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2004004771
	Date:	15.01.2004
	Language:	EN
	[2004/03]
	Type:	A1 Application with search report
	No.:	EP1537878
	Date:	08.06.2005
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 15.01.2004 takes the place of the publication of the European patent application.
	[2005/23]
	Type:	B1 Patent specification
	No.:	EP1537878
	Date:	22.09.2010
	Language:	EN
	[2010/38]
Search report(s)	International search report - published on:	JP	15.01.2004
	(Supplementary) European search report - dispatched on:	EP	26.10.2006
Classification	IPC:	A61K45/00, A61K38/17, A61K39/395, A61K31/7088, A61P31/00, A61P35/00, A61P35/04, A61P37/04, C12N5/10, C12Q1/02, G01N33/50, A61K35/14, A61K33/00, A61K35/00, G01N33/574, A01K67/027, A61K31/00, // C07K16/28, C07K14/705, C07K16/46	[2006/46]
	CPC:	C07K16/2818 (EP,US); A61K31/7088 (EP,US); A61K38/1774 (EP,US); A61K38/212 (EP,US); A61K39/3955 (US); A61K45/06 (US); (+) A61K47/02 (US); A61K47/26 (US); A61K9/0019 (US); A61P1/16 (EP); A61P11/00 (EP); A61P31/00 (EP); A61P31/04 (EP); A61P31/10 (EP); A61P31/12 (EP); A61P31/14 (EP); A61P31/16 (EP); A61P31/18 (EP); A61P31/20 (EP); A61P31/22 (EP); A61P33/06 (EP); A61P35/00 (EP); A61P35/02 (EP); A61P35/04 (EP); A61P37/04 (EP); A61P37/06 (EP); A61P43/00 (EP); C07K14/70521 (US); C07K16/18 (US); C07K16/2803 (US); C07K16/2827 (EP,US); C12Q1/025 (EP,US); G01N33/5011 (EP,US); G01N33/574 (EP,US); A61K2039/505 (EP,US); A61K2039/507 (US); C07K2317/21 (US); C07K2317/24 (US); C07K2317/54 (EP,US); C07K2317/73 (EP,US); C07K2317/76 (EP,US); C07K2319/30 (US); G01N2500/00 (EP,US); Y02A50/30 (EP,US) (-)
	Former IPC [2005/23]	A61K45/00, A61K38/17, A61K39/395, A61K31/7088, A61P31/00, A61P35/00, A61P35/04, A61P37/04, C12N5/10, C12Q1/02, G01N33/50, A61K6/027
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/23]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
Title	German:	IMMUNPOTENZIERENDE ZUSAMMENSETZUNGEN	[2005/23]
	English:	IMMUNOPOTENTIATING COMPOSITIONS	[2005/23]
	French:	COMPOSITIONS IMMUNOSTIMULANTES	[2005/23]
Biological material	This application mentions deposited biological material, check the file for details
Entry into regional phase	03.01.2005	Translation filed
	03.01.2005	National basic fee paid
	03.01.2005	Search fee paid
	03.01.2005	Designation fee(s) paid
	03.01.2005	Examination fee paid
Examination procedure	06.01.2004	Request for preliminary examination filed International Preliminary Examining Authority: JP
	03.01.2005	Examination requested [2005/23]
	24.03.2005	Amendment by applicant (claims and/or description)
	25.06.2007	Despatch of a communication from the examining division (Time limit: M06)
	07.01.2008	Reply to a communication from the examining division
	25.04.2008	Despatch of a communication from the examining division (Time limit: M04)
	28.08.2008	Reply to a communication from the examining division
	17.08.2009	Despatch of a communication from the examining division (Time limit: M02)
	27.10.2009	Reply to a communication from the examining division
	10.03.2010	Communication of intention to grant the patent
	14.05.2010	Fee for grant paid
	14.05.2010	Fee for publishing/printing paid
Divisional application(s)	EP10161767.8 / EP2206517
	EP10172772.5 / EP2243493
	EP17196173.3 / EP3287144
Opposition(s)	Opponent(s)	01 20.06.2011 ADMISSIBLE Merck & Co. 126 East Lincoln Avenue, Mail Stop: RY60-30 Rahway, NJ 07065-0907 / US Opponent's representative Vossius & Partner Patentanwälte Rechtsanwälte mbB, et al, et al Siebertstrasse 3 81675 München / DE
		[N/P]
	Former [2011/30]
	Opponent(s)	01 20.06.2011 ADMISSIBLE Merck & Co. 126 East Lincoln Avenue, Mail Stop: RY60-30 Rahway, NJ 07065-0907 / US Opponent's representative Vossius & Partner, et al, et al Siebertstrasse 4 81675 München / DE
	02.08.2011	Invitation to proprietor to file observations on the notice of opposition
	13.02.2012	Reply of patent proprietor to notice(s) of opposition
	04.06.2014	Date of oral proceedings
	05.09.2014	Despatch of minutes of oral proceedings
	24.09.2014	Date of despatch of rejection of opposition
	26.01.2017	Legal effect of rejection of opposition [2018/03]
Appeal following opposition	01.10.2014	Appeal received No. T1994/14
	03.02.2015	Statement of grounds filed
	26.01.2017	Result of appeal procedure: appeal of the opponent withdrawn
Fees paid	Renewal fee
	29.07.2005	Renewal fee patent year 03
	28.07.2006	Renewal fee patent year 04
	30.07.2007	Renewal fee patent year 05
	31.03.2008	Renewal fee patent year 06
	30.07.2009	Renewal fee patent year 07
	30.07.2010	Renewal fee patent year 08
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CY	22.09.2010
	EE	22.09.2010
	RO	22.09.2010
	SI	22.09.2010
	SK	22.09.2010
	BG	22.12.2010
	MC	31.07.2011
	[2013/42]
Former [2011/31]	EE	22.09.2010
	RO	22.09.2010
	SI	22.09.2010
	SK	22.09.2010
Former [2011/23]	EE	22.09.2010
	SI	22.09.2010
	SK	22.09.2010
Former [2011/10]	SI	22.09.2010
Documents cited:	Search	[X]WO0114557 (DANA FARBER CANCER INST INC [US], et al);
		[X]WO0200730 (GENETICS INST [US], et al);
		[PX]WO02078731 (WYETH CORP [US]);
		[PX]EP1591527 (ONO PHARMACEUTICAL CO [JP], et al);
	International search	[X]EP0670369 (ONO PHARMACEUTICAL CO [JP], et al);
		[X]WO0114557 (DANA FARBER CANCER INST INC [US], et al);
		[X]WO0200730 (GENETICS INST [US], et al);
		[X]WO0200692 (GENETICS INST [US], et al);
		[XP]WO02078731 (WYETH CORP [US]);
		[XP]WO03011911 (ONO PHARMACEUTICAL CO [JP], et al);
		[XP]WO03042402 (DANA FARBER CANCER INST INC [US], et al);
	Examination	WO2006121168

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p